Chai Discovery Secures $130 Million in Series B Funding, Valued at $1.3 Billion
Chai Discovery, an AI-driven biotech firm backed by OpenAI, has raised $130 million in a Series B funding round, achieving a valuation of $1.3 billion. The company focuses on developing advanced tools for drug discovery, particularly in predicting molecular interactions. This funding will enhance its capabilities in designing AI-driven molecules for potential cures.
Chai Discovery Secures $130 Million in Series B Funding, Valued at $1.3 Billion
Chai Discovery, an AI-driven biotech firm backed by OpenAI, has raised $130 million in a Series B funding round, achieving a valuation of $1.3 billion. The company focuses on developing advanced tools for drug discovery, particularly in predicting molecular interactions. This funding will enhance its capabilities in designing AI-driven molecules for potential cures.
Why World Pulse Now
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
Our system has analyzed 3,548 articles worldwide
~147 per hour
248 trending stories shaping headlines
From breaking news to viral moments
Monitoring 309 trusted sources
Major outlets & specialized publications
Latest update 2 days ago
Always fresh
Featured Products
View the complete directory of tools and products.


